3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
13
Burkitt Lymphoma
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Biphenotypic, Acute
3
Smoldering Multiple Myeloma
2
Neoplasm Metastasis
2
Lymphoma, Mantle-Cell
2
Lung Neoplasms
2
Immunoglobulin Light-chain Amyloidosis
2
Down Syndrome
2
Carcinoma, Non-Small-Cell Lung
2
Recurrence
1
Neoplasms
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Plasma Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Hodgkin Disease
1
Fatigue
1
Brain Neoplasms
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Blast Crisis
1
Ann Arbor Stage II Mantle Cell Lymphoma
1
Interventions
fludarabine
25
Cyclophosphamide
20
Azacitidine
20
venetoclax
18
Specimen Handling
18
fludarabine phosphate
17
Mycophenolic Acid
14
Melphalan
14
Busulfan
14
Biopsy
14
Whole-Body Irradiation
13
Tacrolimus
12
Cytarabine
12
Granulocyte Colony-Stimulating Factor
10
decitabine and cedazuridine drug combination
9
Decitabine
9
Stem Cell Transplantation
8
Sirolimus
8
Injections
8
Filgrastim
8
Cyclosporine
8
Peripheral Blood Stem Cell Transplantation
7
Thiotepa
6
ruxolitinib
5
X-Rays
5
Idarubicin
5
Magnetic Resonance Spectroscopy
4
Cladribine
4
CPX-351
4
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
auricularum
×
90 days
×
Clear all
No trials found.